EndoCure

EndoCure is a medical deep-tech startup founded in Haifa, Israel, in November 2023 by CEO Hadas Ziso and Moshe Shoham. Ziso, who holds degrees in biomedical engineering and an MBA, was inspired to create EndoCure to address the significant unmet needs in women's health, specifically targeting endometriosis. Her co-founder, Moshe Shoham, is an expert in medical robotics.

The company is developing an advanced diagnostic tool for endometriosis, a condition affecting 10% of women of reproductive age. EndoCure's core product, Revealan™, is an AI-powered, robotic ultrasound assistant platform designed to improve the detection, mapping, and staging of endometriosis lesions. The technology integrates a robotic scanning arm, compatible with standard ultrasound devices, to produce high-resolution 3D volumetric data. This operator-independent system aims to provide objective imaging, allowing AI algorithms to analyze the data and create a complete map of lesions, thereby enhancing diagnostic accuracy and informing surgical planning.

EndoCure's solution addresses the limitations of current imaging techniques, which often fail to detect most endometriosis lesions, leading to diagnostic delays. The company's business model centers on providing this technology to healthcare providers to improve patient outcomes. EndoCure operates in the Health Tech and Life Sciences sector, with a focus on Femtech. The company has secured seed funding totaling $2.05 million from investors including InvenTech, the Israel Innovation Authority (IIA), and Teuza Fund. It has also won several accolades, including the MassChallenge 2024, and has obtained patents for its technology.

Keywords: endometriosis, robotic ultrasound, medical imaging, AI diagnostics, femtech, 3D imaging, surgical planning, medical robotics, health tech, lesion mapping